JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 49:347-349, doi:10.1016/j.jacc.2006.10.032
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JACC
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayan, S. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Narayan, S. M.

EDITORIAL COMMENT

T-Wave Alternans and Human Ventricular Arrhythmias

What Is the Link?*

Sanjiv M. Narayan, MB, MD, FACC*

Electrophysiology Service, VA San Diego, La Jolla, California; and the University of California San Diego, San Diego, California.

* Reprint requests and correspondence: Dr. Sanjiv M. Narayan, Electrophysiology Service, VA San Diego, University of California San Diego, Box 111A, 3350 La Jolla Village Drive, San Diego, California 92161. (Email: snarayan{at}ucsd.edu).


Sudden cardiac arrest (SCA) from ventricular arrhythmias affects over 400,000 individuals/year in the U.S. alone and has a dismal survival rate (1). Although reduced left ventricular systolic function (i.e., left ventricular ejection fraction) (2) and symptomatic heart failure (i.e., congestive heart failure) (3) are the major predictors of risk for SCA, they are more sensitive than they are specific. Thus, their primacy in guidelines for implantable cardioverter-defibrillators (ICDs) might lead to potentially unnecessary implantations (1). This motivates the identification of markers for the pathophysiology of ventricular arrhythmias that can improve indices for ICD insertion.

Several candidates exist. Inducing sustained ventricular arrhythmias at electrophysiologic study (EPS) was historically the gold standard but has become tarnished of late. Certainly, SCA is more frequent in ischemic cardiomyopathy patients with positive EPS, yet those with negative EPS still have a substantial arrhythmic risk (4,5). The precise reasons why the initiation of ventricular arrhythmias at EPS suboptimally predicts outcome or why EPS is less useful in non-ischemic cardiomyopathy are unclear (1). Therefore, attention has turned to indices of slow conduction and exaggerated dispersion of repolarization that are central to reentrant arrhythmogenesis. Evidence for slowed conduction after myocardial infarction, assessed indirectly by the signal averaged electrocardiogram (ECG) (6), successfully predicted SCA in the MUSTT (Multicenter Unsustained Tachycardia Trial) (7). Elevated sympathetic nervous activity increases the dispersion of repolarization and—when detected by cardiac nuclear imaging (8), reduced heart rate variability (9), or heart rate turbulence (10)—predicts events after myocardial infarction. Ventricular stretch slows conduction and exaggerates repolarization dispersion (11), and accordingly, elevated serum levels of B-type natriuretic peptide predict SCA in cardiomyopathy patients (12).

T-wave alternans (TWA) is a promising ECG risk factor that indicates alternate-beat changes in T-wave shape or amplitude and reflects repolarization dispersion (13). In a decade of contemporary clinical use (14), TWA has shown a negative predictive accuracy for SCA above 90% in a cumulative population of thousands of cardiomyopathy patients, both ischemic and non-ischemic (15,16). Accordingly, Markov models suggest that TWA should improve the economics of ICD insertion (17).

So, then, is TWA a fully developed risk stratifier? To be elevated in status above that of a mere epiphenomenon, an ideal risk stratifier must be plausible, predictive, and pathophysiological. Certainly, TWA meets the first 2 criteria. However, a divide exists between animal studies—where TWA has been linked with repolarization dispersion and arrhythmias, albeit under extreme conditions of acute ischemia, hypothermia, very rapid pacing, or drug pro-arrhythmia (13,18–20)—and the dearth of clinical studies linking TWA with arrhythmogenesis under the conditions that might precede SCA.

In this issue of the Journal, Selvaraj et al. (21) provide important data to bridge this divide. In a small population of patients with ischemic and nonischemic cardiomyopathy, the authors compared ECG TWA with intracardiac repolarization alternans (RPA), using multipole catheters in the right ventricular endocardium and, via the anterior interventricular vein, the left ventricular epicardium. The spatial and temporal concordances that they describe strengthen the pathophysiologic basis of TWA and suggest ways in which it could be further refined as a clinical tool.

Selvaraj et al. (21) report that RPA was seen at more intracardiac sites in patients with than without TWA, consistent with the step-down in alternans magnitude seen from the heart to the T-wave in isolated rabbit (22) and guinea pig (20) hearts. This poses the question of what RPA magnitude contributes to lethal ventricular arrhythmias. Addressing this question requires studies of RPA in control subjects without left ventricular dysfunction, which might help explain "false-positive" tests that diminish the positive predictive value of TWA for SCA (13). It also requires comparison against arrhythmic outcome that was not reported by Selvaraj et al. (21) but could be used to define receiver-operating characteristics of RPA for SCA in a larger cohort.

Selvaraj et al. (21) also report that RPA was spatially non-uniform and more prevalent in left ventricular epicardial than right ventricular endocardial sites. Normal rabbit hearts also show maximal RPA in the left ventricular free wall (22). Although sites of maximal RPA might vary dynamically (20), one might hypothesize that RPA in ischemic cardiomyopathy is maximal near scar and that patient-tailored spatial analysis could optimize the utility of TWA. Indeed, the TWA vector was recently shown to reflect echocardiographic scar in patients with ischemic cardiomyopathy (23), and cardiomyopathy patients with more extensive TWA (i.e., in more ECG leads) have more arrhythmic events (24). Selvaraj et al. (21) also suggest a transmural gradient in RPA, yet their recordings did not span the same myocardial region, so this needs further validation.

Notably, spatial non-uniformity in RPA suggests a mechanism by which unfortunately timed beats might encounter regional block to initiate re-entry. In animals, spatially non-uniform RPA after premature beats, rapid pacing (20), or acute ischemia (18) might lead to discordant alternans, where juxtaposed myocardial regions alternate with opposite phase, leading to unidirectional block, re-entry, and ventricular fibrillation (18,20). The "discordance" noted in patients by Selvaraj et al. (21) is likely different, not just because no patient imminently developed ventricular arrhythmias but also because of the integrative effects of unipolar recordings and their T waves. First, by averaging a wide field, unipolar recordings might not reflect homogeneous region whose cells all alternate with 1 phase so that the line of block needed to initiate reentry might not form (20). Second, unipolar "T waves" integrate many action potentials and have arbitrary polarity, unlike action potentials. Discordant RPA could thus reflect differences in baseline T-wave polarity between sites rather than discordant cellular alternans. Nevertheless, it is important to study arrhythmic outcome in patients with discordant RPA or an ECG TWA surrogate. We recently reported that premature beats, which produced discordant RPA in some patients reported by Selvaraj et al. (21), might reverse the phase of ECG TWA in cardiomyopathy patients. Such patients went on to suffer a markedly worse outcome than those with TWA but without phase reversal (25). Studies are needed to verify whether TWA phase reversal or another index reflects a particularly pro-arrhythmic intracardiac dispersion of repolarization.

Selvaraj et al. (21) should be commended on their novel and important study that begins to link TWA with dispersion of ventricular repolarization and arrhythmogenesis in humans. Future work should relate RPA to regional structural abnormalities and to the rate-dynamics of action potential duration (26). In particular, it is important to define the routes leading to spatial non-uniformity and their relation to arrhythmic outcome. Such studies might help define TWA indices of dynamic arrhythmic susceptibility and, in parallel, shed valuable insights into human ventricular arrhythmogenesis.


    Footnotes
 
This work was supported by grants from the National Heart, Lung, and Blood Institute (HL70529) and Doris Duke Charitable Foundation. Dr. Narayan received speaking honoraria from Cambridge Heart, the manufacturers of the T-wave alternans equipment, in 2002 and 2004 (combined total for both years under $10,000) and is a member of the speaker’s bureau for Guidant/Boston Scientific Corporation.

* Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Back


    References
 Top
 References
 

  1. Josephson ME, Wellens HJJ. Implantable defibrillators and sudden cardiac death Circulation 2004;109:2685-2691.
  2. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 2002;346:877-883.[Abstract/Free Full Text]
  3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure N Engl J Med 2005;352:225-237.[Abstract/Free Full Text]
  4. Buxton AE, Lee KL, Carlo LD, et al. Multicenter Unsustained Tachycardia Trial Investigators (MUSTT) Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death N Engl J Med 2000;342:1937-1945.[Abstract/Free Full Text]
  5. Daubert JP, Zareba W, Hall WJ, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients J Am Coll Cardiol 2006;47:98-107.[Abstract/Free Full Text]
  6. Hood MA, Pogwizd SM, Peirick J, Cain ME. Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal-averaged ECGs Circulation 1992;86:1888-1901.
  7. Gomes JA, Cain ME, Buxton AE, Josephson ME, Lee KL, Hafley GE. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction Circulation 2001;104:436-441.
  8. Arora R, Ferrick KJ, Nakata T, et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator J Nucl Cardiol 2003;10:121-131.[CrossRef][ISI][Medline]
  9. Farrell TG, Odemuyiwa O, Bashir Y, et al. Prognostic value of Baroreflex sensitivity testing after acute myocardial infarction Br Heart J 1992;67:129-137.[Abstract/Free Full Text]
  10. Schmidt G, Malik M, Barthel P, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction Lancet 1999;353:1390-1396.[CrossRef][ISI][Medline]
  11. Mills R, Narayan S, McCulloch A. The effects of wall stretch on ventricular conduction and refractoriness in the whole heartIn: Kohl P, Sachs F, Franz MR, editors. Cardiac Mechano-Electric Feedback and Arrhythmias: From Pipette to Patient. Philadelphia, PA: Elsevier/Saunders; 2005. pp. 127-136.
  12. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 2002;105:2392-2397.
  13. Narayan SM. T-wave alternans and the susceptibility to ventricular arrhythmias J Am Coll Cardiol 2006;47:269-281.[Abstract/Free Full Text]
  14. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias N Engl J Med 1994;330:235-241.[Abstract/Free Full Text]
  15. Bloomfield DM, Bigger JT, Steinman RC, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction J Am Coll Cardiol 2006;47:456-463.[Abstract/Free Full Text]
  16. Chow T, Kereiakes D, Bartone C, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy J Am Coll Cardiol 2006;47:1820-1827.[Abstract/Free Full Text]
  17. Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population J Am Coll Cardiol 2006;48:112-121.[Abstract/Free Full Text]
  18. Hashimoto H, Asano M, Nakashima M. Alternation in refractoriness and in conduction delay in the ischemic myocardium associated with the alternation in the ST-T complex during acute coronary occlusion in anesthetized dogs J Electrocardiol 1986;19:77-84.[ISI][Medline]
  19. Nearing BD, Huang AH, Verrier RL. Dynamic tracking of cardiac vulnerability by complex demodulation of the T-wave Science 1991;252:437-440.[Abstract/Free Full Text]
  20. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation Circulation 1999;99:1385-1394.
  21. Selvaraj RJ, Picton P, Nanthakumar K, Mak S, Chauhan VS. Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans J Am Coll Cardiol 2007;49:338-346.[Abstract/Free Full Text]
  22. Zabel M, Mauss O, Lim K, Franz MR, Hohnloser SH. Microvolt and macrovolt alternans of action potentials and the T wave in an isolated rabbit heart model(abstr) Circulation 1998;98:I10.
  23. Narayan SM, Smith JM, Lindsay BD, Cain ME, Davila-Roman VG. Relation of T-wave alternans to regional left ventricular dysfunction and eccentric hypertrophy secondary to coronary artery disease Am J Cardiol 2006;97:775-780.[CrossRef][ISI][Medline]
  24. Klingenheben T, Ptaszynski P, Hohnloser S. Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure J Cardiovasc Electrophysiol 2005;16:620-624.[CrossRef][ISI][Medline]
  25. Narayan SM, Smith JM, Schechtman KB, Lindsay BD, Cain ME. T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival Heart Rhythm 2005;2:234-241.[CrossRef][ISI][Medline]
  26. Koller ML, Maier SKG, Gelzer AR, Bauer WR, Meesmann M, Gilmour Jr RF. Altered dynamics of action potential restitution and alternans in humans with structural heart disease Circulation 2005;112:1542-1548.

Related articles in JACC:

Endocardial and Epicardial Repolarization Alternans in Human Cardiomyopathy: Evidence for Spatiotemporal Heterogeneity and Correlation With Body Surface T-Wave Alternans
Raja J. Selvaraj, Peter Picton, Kumaraswamy Nanthakumar, Susanna Mak, and Vijay S. Chauhan
JACC 2007 49: 338-346. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JACC
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayan, S. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Narayan, S. M.


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK